High Point Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.5K Hold
123
– – 0.01% 208
2026
Q2
$19.2K Hold
123
– – 0.02% 189
2026
Q1
$18.8K Hold
123
– – 0.02% 190
2025
Q4
$16.9K Buy
+123
New +$16.1K 0.02% 198

Other funds holding NVS

High Point Wealth Management's NVS Position: Q3 2026 in Review

High Point Wealth Management held its Novartis (NVS) position steady in Q3 2026 at 123 shares worth $17.5K. The position accounts for 0.01% of the portfolio, ranked #208.

High Point Wealth Management first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $19.2K in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • High Point Wealth Management held 123 shares of Novartis worth $17.5K as of Q3 2026.
  • High Point Wealth Management left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.01% of High Point Wealth Management's portfolio in Q3 2026, its #208 holding.
  • High Point Wealth Management first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
  • High Point Wealth Management's Novartis position peaked at $19.2K in Q2 2026.
  • 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on High Point Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.